Steven Ades
Associate Professor
Division of Hematology and Oncology
University of Vermont
United States of America
Biography
Prof Steven Ades, has received his McGill University, Montreal, Canada; MDCM. Currently, he is working as Professor in department of Hematology and Oncology. He has successfully completed his Administrative responsibilities as Professor.
Research Interest
These include clinical research around adjuvant treatment options for patients with esophageal and stomach cancers, supportive care for patients undergoing abdominal radiation therapy including novel combinations of antiemetics in this setting (AVERT trial: NCT00970905), and the protective impact of lipid lowering agents called statins on the risk of venous blood clots in patients with advanced cancer. I also participate in many national cooperative group trials covering the cancer sites listed above.
Publications
-
O'Toole J, Ades S, Waters BL, Agarwal Z, Lamba G. (2015)Delayed human herpes virus 6 encephalitis in a patient with allogeneic stem cell transplant.56(9):2709-10.
-
Mori M, Ji Y, Kumar S, Ashikaga T, Ades S.(2017)Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.22(2):397-404.
-
Ades S, Halyard M, Wilson K, Ashikaga T, Heimann R, Kumar S, Blackstock W.(2017)Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT).25(5):1503-1510.
